// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Stability of blood eosinophils over time in patients with asthma

Katia Mc Verhamme - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

High prevalence of mild asthma among asthmatics visiting emergency department (ED)

Zafeiria Barmparessou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Proteobacteria phylum association with airway- and emphysema-dominant COPD phenotypes defined by computed tomography

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study

Bo Ding - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Is there an endotype to the treatable eosinophilic trait of chronic obstructive pulmonary disease (COPD)

Olivia Walsh - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD

Nicolai Obling - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Bronchoscopy and laryngoscopy findings in refractory chronic cough (RCC)

James Wingfield Digby - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD)

Catherine Spilling - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Prevalence, incidence, and characteristics of chronic cough among adults from the canadian longitudinal study on ageing (CLSA)

Imran Satia - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of objective 24 hour cough monitoring to measure clinical improvement in cystic fibrosis

Kayleigh Brindle - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Productive Cough, a Forgotten Phenotype of Refractory Chronic Cough

Jenny King - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A novel approach to the analysis of ambulatory 24hr cough monitoring data

Rachel Thompson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Modelling Rhinovirus-16 (RV16) Infection using Human Precision Cut Lung Slices (PCLS)

Rebecca Stinson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

ICAM-1

Longitudinal quality of life following acute NIV for ECOPD

Nicholas Lane - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sub-glottic Stenosis: An orphan tracheopathy – a great asthma mimic!

Sana Iftikhar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Improving the appropriate use of Mannitol challenge testing in a large teaching hospital

Jessica Bradley - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Use of Lung Clearance Index (LCI) to distinguish asthmatics within a symptomatic population

Laura Healy - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Prevalence of pre-operative airflow obstruction in high risk patients without prior COPD diagnosis

Tom Chambers - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS

Mehrdad Arjomandi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Definition, characteristics and quality of life of patients with chronic cough from the Isala chronic cough clinic in the Netherlands

J W K Van Den Berg - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved